Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-17 to 2024-06-27
Current total value of award: $74.1
Description: 8510701589!TYPHOID VI POLYSACC